UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034622
Receipt number R000039473
Scientific Title Establishment of registry system for IgG4-related disease and analysis of the data and the samples
Date of disclosure of the study information 2018/10/24
Last modified on 2024/02/16 09:58:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of registry system for IgG4-related disease and analysis of the data and the samples

Acronym

Establishment of registry system for IgG4-related disease

Scientific Title

Establishment of registry system for IgG4-related disease and analysis of the data and the samples

Scientific Title:Acronym

Establishment of registry system for IgG4-related disease

Region

Japan


Condition

Condition

IgG4-related disease

Classification by specialty

Medicine in general Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To transmit new clinical information of IgG4-related disease, and clarify the pathogenesis and develop a novel treatment.

Basic objectives2

Others

Basic objectives -Others

Identify the clinical characteristics of IgG4-related disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We perform the analysis of the clinical data and samples every year.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with IgG4-related disease, who are over 20 years old

Key exclusion criteria

None

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Takahashi

Organization

Sapporo Medical University School of Medicine

Division name

Department of Rheumatology and Clinical Immunology

Zip code

0608543

Address

South 1-West 16, Chuo-ku, Sapporo

TEL

011-611-2111

Email

htakahas@sapmed.ac.jp


Public contact

Name of contact person

1st name Motohisa
Middle name
Last name Yamamoto

Organization

Sapporo Medical University School of Medicine

Division name

Department of Rheumatology and Clinical Immunology

Zip code

0608543

Address

South 1-West 16, Chuo-ku, Sapporo

TEL

011-611-2111

Homepage URL


Email

mocha@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Sapporo Medical University Hospital

Address

S1-W16, Chuo-ku, Sapporo

Tel

011-611-2111

Email

ji-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 01 Day

Date of IRB

2013 Year 01 Month 16 Day

Anticipated trial start date

2013 Year 01 Month 16 Day

Last follow-up date

2022 Year 12 Month 01 Day

Date of closure to data entry

2022 Year 12 Month 01 Day

Date trial data considered complete

2022 Year 12 Month 01 Day

Date analysis concluded

2022 Year 12 Month 31 Day


Other

Other related information

Collection of the cases


Management information

Registered date

2018 Year 10 Month 24 Day

Last modified on

2024 Year 02 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039473


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name